Acurx PharmaceuticalsACXP
13F holders, Q3 2024 (September 30)22holders −3
1new positions
4sold out
$1.90avg. 13F price*
At the end of Q3 2024, 22 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, down 3 from Q2 2024. 1 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($1.0M), Prospect Financial Services LLC ($561K) and Geode Capital Management, LLC ($278K).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M104
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $34K |
| Exits | 4 | $25K |
All 13F filers, Q2 2024 → Q3 2024: 88,930 shares bought and 30,111 shares sold, net +58,819 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Vanguard Group Inc. | 0.00% | Add +7.7% | 529,349 | $1.0M |
| Prospect Financial Services LLC | 0.35% | Add +6.1% | 295,075 | $561K |
| Geode Capital Management, LLC | 0.00% | Add +12.7% | 146,500 | $278K |
| Morgan Stanley | 0.00% | Reduce -0.4% | 46,201 | $88K |
| LPL Financial LLC | 0.00% | Reduce -16.7% | 44,780 | $85K |
| State Street Corp. | 0.00% | No change | 43,466 | $83K |
| BlackRock, Inc. | 0.00% | — | 28,535 | $54K |
| Northern Trust Corp. | 0.00% | No change | 27,286 | $52K |
| Lanark Financial, Inc. | 0.00% | No change | 19,000 | $36K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 18,656 | $36K |
| StoneX Group Inc. | 0.00% | New | 17,800 | $34K |
| Osaic Holdings, Inc. | 0.00% | Reduce -6.6% | 14,210 | $27K |
| Patriot Financial Group Insurance Agency, LLC | 0.00% | No change | 10,385 | $20K |
| Tocqueville Asset Management L.P. | 0.00% | No change | 10,000 | $19K |
| Semmax Financial Advisors Inc. | 0.00% | No change | 5,879 | $11K |
| Cornerstone Planning Group LLC | 0.00% | No change | 3,344 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -50.1% | 2,065 | $4K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 1,636 | $3K |
| Simplex Trading, LLC | 0.00% | Reduce -60.2% | 1,161 | $2K |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 500 | $950 |
| Group One Trading LLC | 0.00% | Reduce -96.7% | 173 | $329 |
| Bank of America Corp. | 0.00% | Add +7.6% | 113 | $215 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.